Home
Conditions
Paraproteinemias

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,008 public trials 572 recruiting studies

Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

Safety and PK/PD of TG-0054 in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients

NCT01018979

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations: Chang-Gung Memorial Hospital Chiayi Chiayi City, Taiwan

Buddist Tzu Chi General Hospital Hualien City, Taiwan

Kaohsiung Medical University Hospital Kaohsiung City, Taiwan

Chang-Gung Memorial Hospital Linkou Linkou District, Taiwan

View Trial Details

Completed

Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma

NCT02037256

Conditions: Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, +130 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies

NCT02129582

Conditions: Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +44 more
Locations: University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Daratumumab for the Treatment of Patients With AL Amyloidosis

NCT02841033

Conditions: AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations: Boston Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Comparison of Geriatric Screening Methods in Newly Diagnosed Multiple Myeloma Patients

NCT02918695

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: ZNA Antwerpen Antwerp, Belgium

Centre Hospitalier EpiCURA Baudour, Belgium

Imelda Ziekenhuis Bonheiden, Belgium

AZ Klina Brasschaat, Belgium

View all 20 locations

View Trial Details

Completed

Bortezomib, Dexamethasone, and Rituximab in Previously Untreated Patients With Waldenstrom's Macroglobulinemia

NCT01046006

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Alexandra Hospital , Department of Clinical Therapeutics Athens, Attica, Greece

Laikon Hospital Athens, Attica, Greece

Erasmus Medical Center Rotterdam, Netherlands

Hospital Universitario de Salamanca Salamanca, Spain

View Trial Details

Completed

Lenalidomide, Dexamethasone and Cyclophosphamide in Amyloidosis (AL)

NCT00981708

Conditions: Amyloidosis, Disease Attributes, Immune System Diseases, +13 more
Locations: Alexandra Hospital , Department of Clinical Therapeutics Athens, Attica, Greece

View Trial Details

Completed

Pomalidomide in Gene Expression Profiling (GEP)-Defined High-risk Multiple Myeloma

NCT01177735

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations: University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy Little Rock, Arkansas, United States

View Trial Details

Completed

High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors

NCT00536601

Conditions: Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +137 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients

NCT02104427

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations: Stony Brook University Hospital Stony Brook, New York, United States

Tennessee Oncology, PLLC Nashville, Tennessee, United States

View Trial Details

Paraproteinemias

Paraproteinemias trial results

Related conditions